Proto Labs (PRLB) Expected to Announce Earnings on Friday

Proto Labs (NYSE:PRLB) is anticipated to issue its Q2 2026 results before the market opens on Friday, July 31st. Analysts expect Proto Labs to post earnings of $0.54 per share and revenue of $144.5330 million for the quarter. Proto Labs has set its Q2 2026 guidance at 0.500-0.580 EPS. Parties may visit the the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Friday, July 31, 2026 at 8:30 AM ET.

Proto Labs (NYSE:PRLB) last announced its quarterly earnings data on Friday, May 1st. The industrial products company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Proto Labs had a return on equity of 4.15% and a net margin of 4.71%.The business had revenue of $139.34 million during the quarter, compared to the consensus estimate of $135.31 million. During the same period in the previous year, the company posted $0.33 earnings per share. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. On average, analysts expect Proto Labs to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Proto Labs Stock Performance

PRLB stock opened at $71.60 on Thursday. The company’s 50 day moving average price is $76.83 and its 200 day moving average price is $66.50. Proto Labs has a fifty-two week low of $38.62 and a fifty-two week high of $83.15. The firm has a market capitalization of $1.70 billion, a price-to-earnings ratio of 67.55 and a beta of 1.38.

Insider Transactions at Proto Labs

In other news, insider Michael R. Kenison sold 16,030 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $69.49, for a total transaction of $1,113,924.70. Following the sale, the insider owned 18,683 shares of the company’s stock, valued at approximately $1,298,281.67. This trade represents a 46.18% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Sven Wehrwein sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $77.28, for a total value of $154,560.00. Following the sale, the director owned 32,505 shares of the company’s stock, valued at approximately $2,511,986.40. The trade was a 5.80% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 25,663 shares of company stock worth $1,804,727. Company insiders own 1.30% of the company’s stock.

Institutional Trading of Proto Labs

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in PRLB. Bank of Montreal Can acquired a new stake in shares of Proto Labs during the fourth quarter worth about $202,000. Polen Capital Management LLC acquired a new stake in shares of Proto Labs in the 4th quarter valued at about $210,000. Cerity Partners LLC acquired a new stake in shares of Proto Labs in the 4th quarter valued at about $214,000. Prelude Capital Management LLC purchased a new position in Proto Labs during the 3rd quarter worth approximately $264,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Proto Labs by 28.6% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,456 shares of the industrial products company’s stock worth $273,000 after buying an additional 1,215 shares during the last quarter. Institutional investors and hedge funds own 84.54% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on PRLB. Weiss Ratings upgraded shares of Proto Labs from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, July 17th. Zacks Research downgraded shares of Proto Labs from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 3rd. Wall Street Zen lowered shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a report on Saturday, July 18th. Finally, Benchmark lifted their price objective on shares of Proto Labs from $70.00 to $91.00 and gave the stock a “buy” rating in a research report on Thursday, July 2nd. Four equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $65.33.

About Proto Labs

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.